Takeda Pharmaceutical Co. (TAK)
(Delayed Data from NYSE)
$13.36 USD
-0.13 (-0.96%)
Updated Jul 19, 2024 04:00 PM ET
5-Strong Sell of 5 5
A Value D Growth A Momentum B VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Bottom 42% (146 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.52 | 9.99 |
Current Quarter Estimate | 0.37 | -2.04 | 61.00 |
Year Ago Quarter Estimate | 0.55 | -0.59 | 54.84 |
Next Quarter Estimate | NA | -2.00 | 63.00 |
Next Year Estimate | 1.42 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -22.75 | 13.10 | 15.67 |
Next Year | 10.08 | 15.90 | 9.31 |
Last 5 Years | 8.30 | 7.00 | 8.10 |
Next 5 Years | 25.40 | 25.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 8.56 | -5.88 |
Price/Book (MRQ) | 0.84 | 1.78 |
Price/Cash Flow (MRFY) | 4.12 | 8.66 |
Dividend Yield | 3.57% | 0.00% |
Net Profit Margin (TTM) | 6.18% | -2,822.50% |
Return on Equity (TTM) | 9.92% | -91.37% |
Debt to Equity (MRQ) | NA | 0.08 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.